Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    Open Studies | "Dyskinesia, Drug-Induced"
Show Display Options
Rank Status Study
1 Unknown  Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia
Condition: Dyskinesia, Drug-Induced
Intervention: Drug: aripiprazole
2 Recruiting Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Conditions: Idiopathic Parkinson's Disease;   Drug Induced Dyskinesia
Interventions: Drug: Topiramate;   Drug: Placebo
3 Recruiting Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Conditions: Chorea;   Drug Induced Dyskinesia;   Movement Disorder;   Muscular Disease;   Tic Disorder
Intervention: Other: Botulinum Toxin
4 Recruiting Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)
Conditions: Dyskinesia, Medication-Induced;   Parkinson's Disease
Interventions: Device: tSMS;   Device: sham

Indicates status has not been verified in more than two years